Literature DB >> 28302279

Venous thromboembolism prophylaxis in the pediatric trauma patient.

John K Petty1.   

Abstract

Although venous thromboembolism (VTE) occurs in less than 1% of hospitalized pediatric trauma patients, care providers must make decisions about VTE prophylaxis on a daily basis. The consequences of VTE are significant; the risks of developing VTE are variable; and the effectiveness of prophylaxis against VTE is not conclusive in children. While the value of VTE prophylaxis is well defined in adult trauma care, it is unclear how this translates to the care of injured children. This review evaluates the incidence and risks of VTE in pediatric trauma and assesses the merits of prophylaxis in children. Pharmacologic prophylaxis against VTE is a reasonable strategy in critically injured adolescent trauma patients. Further study is needed to establish the risks and benefits of VTE prophylaxis across the spectrum of injured children.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deep venous thrombosis; Pediatric; Prevention; Pulmonary embolism; Trauma; Venous thromboembolism

Mesh:

Year:  2017        PMID: 28302279     DOI: 10.1053/j.sempedsurg.2017.01.001

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  3 in total

Review 1.  Venous thromboembolism prophylaxis after pediatric trauma.

Authors:  Christina Georgeades; Kyle Van Arendonk; David Gourlay
Journal:  Pediatr Surg Int       Date:  2021-01-19       Impact factor: 1.827

Review 2.  Characteristics of Deep Venous Thrombosis in Isolated Lower Extremity Fractures and Unsolved Problems in Guidelines: A Review of Recent Literature.

Authors:  Wei-Guang Zhao; Wei-Li Zhang; Ying-Ze Zhang
Journal:  Orthop Surg       Date:  2022-05-27       Impact factor: 2.279

3.  Incidence of venous thromboembolic events not related to vascular catheters in a prospective cohort of critically ill children.

Authors:  Åsa K M Östlund; Urban Fläring; Peter Larsson; Sylvie Kaiser; Lena Vermin; Tony Frisk; Ann Dahlberg; Jonas Berner; Åke Norberg; Andreas Andersson
Journal:  Eur J Pediatr       Date:  2022-06-02       Impact factor: 3.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.